Market Tracker

12/07 1:20pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.50
Delayed Data
As of 1:04pm ET
 -0.23 / -3.42%
Today’s Change
5.60
Today|||52-Week Range
10.51
-23.98%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close6.73
Today’s open6.70
Day’s range6.50 - 6.97
Volume32,151
Average volume (3 months)34,810
Market cap$89.3M
Dividend yield--
Data as of 1:04pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
OHRPOHR Pharmaceutical I...+0.02+0.96%
SPHSSophiris Bio Inc-0.02-0.73%
CASICASI Pharmaceuticals...-0.08-5.86%
SCYXSCYNEXIS Inc-0.07-2.00%
Data as of 1:05pm ET, 12/07/2016

Financials

Last reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts